https://immuno-oncology.euroscicon.com/
[button text=”REGISTER NOW” link=”https://immuno-oncology.euroscicon.com/registration” style=”default” size=”normal” target=”_self” display=”inline” icon=”no”]
Holder of the Declaration: WAMS The World Academy of Medical Sciences
The EuroSciCon welcomes you to attend the Immuno Oncology 2018 focus on Current Advancements and its Applications in Oncology & Immuno Oncology from July 23-24, 2018 in Amsterdam, Netherlands. The theme of this year’s meeting is “Current Advancements and its Applications in Oncology & Immuno Oncology “which will provide an international platform for discussion of present and future challenges in Immunology, Immuno Oncology education, continuing education and expertise meeting. World-leading health Immunologists, clinicians, educators and researchers will present cutting-edge and practical clinical techniques based upon widely accepted evidence and will introduce new and emerging research.
What’s New
Immuno Oncology 2018 includes international attendee workshops, lectures and symposia, including a designated registration area, a refreshment break and gala lunch. Immunologists can join the EuroSciCon as an international member to receive discounts on registration. So come and join leading experts and allied professionals from July 23-24, 2018 in Amsterdam, Netherlands to keep up with the rapidly accelerating pace of change that is already having an impact on the field of Immuno Oncology and will continue to in the future.
The scientific program includes Keynote & Plenary talks, Video Presentations, Poster Presentations and E-Posters. Furthermore, oral communications of (post)doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Oncology & Immuno Oncology and its advancements.
EuroSciCon is the longest running independent life science events company with a predominantly academic client base. Our multi-professional and multi-speciality approach creates a unique experience that cannot be found with a specialist society or commercially.
Euroscicon are corporate members of the following organisations
- Royal Society of Biology
- IBMS
- British Society for Immunology
- Rare Care UK
- Opportunities for Conference Attendees
For Researchers &Faculty:
Speaker Presentations
- Poster Display
- Symposium hosting
- Workshop organizing
For Universities, Associations & Societies:
- Association Partnering
- Collaboration proposals
- Academic Partnering
- Group Participation
For Students & Research Scholars:
- Poster Competition (Winner will get Best Poster Award)
- Young Researcher Forum (YRF Award to the best presenter)
- Student Attendee
- Group registrations
For Business Delegates:
- Speaker Presentations
- Symposium hosting
- Book Launch event
- Networking opportunities
- Audience participation
For Companies:
- Exhibitor and Vendor booths
- Sponsorships opportunities
- Product launch
- Workshop organizing
- Scientific Partnering
- Marketing and Networking with clients
Euroscicon organizes International Nutrition Meetings annually across Europe, Austria, Ireland, Germany, France, Liechtenstein, Lithuania, Finland, Luxembourg, Hungary, Italy, Norway, Poland, Denmark, Macedonia, Greece, Portugal, Romania, Czech Republic, Switzerland, United Kingdom, Belgium, Scotland, Latvia, Ukraine, Sweden, Denmark, Spain, Netherlands Russia, Bulgaria, France, with solitary subject of quickening logical revelations.
Topics:
- Tumors
- Brain Tumors
- Tumor Immunology
- Tumor immunotherapy research
- Cancer Immunology & Immunotherapy
- Types of cancer
- Cancer Research & Cancer vaccines
- Antibody Therapy of Cancer
- Combining Cancer Immunotherapies
- Immune checkpoint inhibitors
- Cancer clinical trials
- Radiology and Imaging in Cancer
- Cancer Prognosis & Diagnosis
- Cancer micro and immuno environment
- Stem Cell Therapy
- Tumor markers and drug targeting
- Tumor biology
- Cancer Pharmacology
- Cancer biomarkers
- Cancer Genomics and Metabolomics
- Cancer & HIV
- Immuno-Oncology studies
- Novel Approaches in Cancer & Tumor
